Genomic profiling for cancer of unknown primary site
Thursday, February 12, 2015 - 18:30
in Biology & Nature
Genomic profiling of cancer of an unknown primary site (CUP) found at least one clinically relevant genomic alteration in most of the samples tested, an indication of potential to influence and personalize therapy for this type of cancer, which responds poorly to nontargeted chemotherapy treatments, according to a study published online by JAMA Oncology.